Jose Gonzales Zamora

Medicine & Life Sciences

1. Infections 100%
2. GS-5734 62%
3. Coronavirus 61%
4. Bacteremia 60%
5. Acute Retroviral Syndrome 55%
6. Transplant Recipients 54%
7. SARS Virus 48%
8. Brain Abscess 45%
9. Splenic Infarction 45%
10. Mycobacterium abscessus 44%
11. Bacillus 42%
12. Acanthamoeba 41%
13. Anti-Bacterial Agents 41%
14. tocilizumab 41%
15. Toxoplasmosis 41%
16. Anti-Retroviral Agents 41%
17. Penicillin-Binding Proteins 41%
18. Actinomycosis 41%
19. Abscess 40%
20. Glucosephosphate Dehydrogenase Deficiency 40%
21. Cryptococcus 40%
22. Transplants 40%
23. Leishmania infantum 40%
24. Actinomyces 39%
25. Therapeutics 38%
26. Latent Tuberculosis 38%
27. Liver Abscess 38%
28. Severe Acute Respiratory Syndrome 37%
29. Catheter-Related Infections 37%
30. Drainage 37%
31. Peru 37%
32. Cutaneous Leishmaniasis 37%
33. Central Nervous System Infections 36%
34. HIV 36%
35. Visceral Leishmaniasis 36%
36. Neisseria gonorrhoeae 35%
37. Leishmaniasis 34%
38. Haemolytic Anaemia 34%
39. Toxoplasma 33%
40. Amphotericin B 32%
41. HIV Infections 32%
42. Methicillin-Resistant Staphylococcus aureus 32%
43. Osteomyelitis 31%
44. Thoracic Wall 31%
45. Kidney 31%
46. Lung 31%
47. Encephalitis 31%
48. Klebsiella pneumoniae 31%